Journal
JOURNAL OF RHEUMATOLOGY
Volume 38, Issue 11, Pages 2376-2381Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.101310
Keywords
LUMICAN; SYSTEMIC LUPUS ERYTHEMATOSUS; SINGLE-NUCLEOTIDE POLYMORPHISMS; SMALL LEUCINE-RICH PROTEOGLYCAN
Categories
Funding
- China Medical University Hospital [DMR 97-062]
- Asia University-China Medical University [CMU98-asia-02]
Ask authors/readers for more resources
Objective. Lumican (LUM) is predominantly localized in areas of pathological fibrosis. To determine whether polymorphisms in LUM gene are associated with development of systemic lupus erythematosus (SLE), we analyzed 2 single-nucleotide polymorphisms (SNP) of LUM in a Taiwan Chinese Han population. Methods. Participants included 168 patients with SLE and 192 age-matched controls in whom examinations had excluded SLE. Genotyping of -628 A/- (rs17018757) and c.1567 T/C polymorphisms in LUM were carried out in each patient and control using the polymerase chain reaction-restriction fragment-length polymorphism method, and validated by Taqman SNP genotyping assay. Data were correlated with the development of SLE and various clinical symptoms by chi-square analysis. Results. Frequencies of C/C genotype and the C allele at c.1567 T/C were significantly higher in patients than controls. Polymorphism at c.1567 C/T was found to be associated with arthritis and photosensitivity in patients with SLE, which are both connective tissue-related symptoms. Conclusion. The c.1567 T/C polymorphism of LUM is related to the development and clinical symptoms of SLE. (First Release Sept 1 2011; J Rheumatol 2011;38:2376-81; doi:10.3899/jrheum.101310)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available